Metropolis Healthcare Limited — Others, 13-05-2025: Change in Management

Metropolis Healthcare Limited has announced a board meeting to approve the financial results for the quarter and half-year. The Board re-appointed Ms. Ameera Shah as Chairperson & Whole-time Director for five years and appointed Mr. Surendran Chemmenkotil as Managing Director; he will step down as CEO soon. Mr. Rehan Khan joined as an Independent Director. New audits by Manish Ghia & Associates and PwC were appointed for five years. Two employee benefit plans (ESOP and RSU) were approved, subject to shareholder consent. The company completed a strategic acquisition of Core Diagnostics for Rs. 218.88 Cr, partly in cash and equity. Tax assessments reflect a probable liability of Rs. 19.64 Cr. Metropolis is focused on growth through technology, expansion, and talent retention.